Leukemia treatment cost in Austria fluctuates based on the disease subtype and necessary therapeutic intensity. Essential leukemia chemotherapy typically ranges from $15,000 to $35,000, while advanced CAR T-cell therapy runs $350,000 to $500,000. Total expenses depend on the clinical stage and hospital tier. Patients often save approximately 30-50% compared to the US. Most specialized hematology centers are located in Vienna and Graz.
Typical Leukemia Treatment Costs in Austria
Bookimed Expert Insight: Patients requiring specialized hematology benefit from consultants like Dr. Johannes Drach at Confraternitaet Private Hospital. His background at M. D. Anderson Cancer Center supports expert management of monoclonal gammopathies. For those seeking targeted cancer therapies, Professor Wolfgang Köstler at Wiener Privatklinik provides advanced immunotherapy protocols. Choosing private clinics in Vienna ensures immediate access to multidisciplinary care and internationally published oncology specialists.
| Turkey | Austria | Spain | |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| CAR T-cell therapy | from $200,000 | from $350,000 | from $330,000 |
| Leukemia chemotherapy | from $8,000 | from $15,000 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia treatment journey.
Univ. Prof. Dr. Wolfgang Köstler is a distinguished Austrian oncologist with over two decades of expertise in personalized cancer treatment at Wiener Privatklinik.
Professor Drach has performed 1,100+ oncology procedures and leads the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital.
Written by Anna Leonova